查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1379188

2023-2028 年按產品類型、篩檢、疾病、最終用戶和地區分類的產前和新生兒基因檢測市場報告

Prenatal and Newborn Genetic Testing Market Report by Product Type, Screening, Disease, End User, and Region 2023-2028
出版日期: | 出版商: IMARC | 英文 147 Pages | 商品交期: 2-3個工作天內

價格

概要

2022年，全球產前和新生兒基因檢測市場規模達到53億美元。展望未來， IMARC Group預計到2028年市場規模將達到112億美元，2022-2028年複合年成長率（CAGR）為13.3%。對先進診斷和篩檢設備的需求不斷成長、世界各地新生兒先天畸形和遺傳異常患病率不斷上升以及醫療行業的蓬勃發展是推動市場的一些關鍵因素。

產前和新生兒基因檢測包括血液檢測、特定類型的超音波檢測和產前遊離 DNA 篩檢，為未出生嬰兒和新生兒的基因組成提供寶貴的見解。它可以識別某些出生缺陷，其中許多是未出生或新生兒的遺傳性疾病。它為準父母、醫療保健專業人員和研究人員提供重要資訊，使他們能夠就嬰兒的健康和福祉做出明智的決定。它有助於改善患者的治療結果並指導醫療干預，同時能夠準確識別懷孕和嬰兒早期的遺傳變異和異常。它還有助於檢測各種先天性疾病，如唐氏症、囊性纖維化、鐮狀細胞疾病和苯酮尿症。由於它有助於分析父母血液中的各種蛋白質水平，以確定嬰兒染色體數量異常的風險，因此全球對產前和新生兒基因檢測的需求正在增加。

產前和新生兒基因檢測市場趨勢：

目前，全球大眾對先進診斷和篩檢設備的需求不斷成長，是支持市場成長的關鍵因素之一。此外，全世界新生兒先天畸形和基因異常的盛行率增加。這與蓬勃發展的醫療產業一起推動了市場的成長。此外，與傳統方法相比，非侵入性產前篩檢方法具有多種優點，例如準確度高、精確度高、痛苦少、診斷快速等，對市場的需求不斷成長，正在對市場產生積極影響。除此之外，人們對產前和新生兒基因檢測的好處的認知不斷提高，為行業投資者提供了利潤豐厚的成長機會。此外，由於注重健康的個人數量不斷增加，對產前和新生兒基因檢測的需求不斷增加，也促進了市場的成長。除此之外，各國政府機構都致力於改善醫療基礎設施，為國民提供更好的醫療服務。為此，主要參與者正在開發基因眼科測試，以確定患者罹患圓錐角膜和其他角膜營養不良的風險。此外，用於檢測遺傳性疾病風險的母體血漿檢測對無細胞 DNA 的需求不斷成長，這提供了有利的市場前景。

本報告回答的關鍵問題：

  • 迄今為止，全球產前和新生兒基因檢測市場表現如何，未來幾年將如何表現？
  • 全球產前和新生兒基因檢測市場的促進因素、限制因素和機會是什麼？
  • 每個促進因素、限制因素和機會對全球產前和新生兒基因檢測市場有何影響？
  • 主要區域市場有哪些？
  • 哪些國家代表了最具吸引力的產前和新生兒基因檢測市場？
  • 依產品類型分類的市場是怎麼樣的？
  • 產前及新生兒基因檢測市場最具吸引力的產品類型為何？
  • 根據篩選，市場的詳細情形如何？
  • 產前及新生兒基因檢測市場哪項篩檢最具吸引力？
  • 基於疾病的市場崩盤是什麼？
  • 產前及新生兒基因檢測市場最具吸引力的疾病是？
  • 基於最終用戶的市場區隔是什麼？
  • 產前和新生兒基因檢測市場中哪一個最有吸引力的最終用戶？
  • 全球產前及新生兒基因檢測市場競爭格局如何？
  • 全球產前和新生兒基因檢測市場的主要參與者/公司有哪些？

目錄

第 1 章：前言

第 2 章：範圍與方法

  • 研究目的
  • 利害關係人
  • 資料來源
    • 主要資源
    • 二手資料
  • 市場預測
    • 自下而上的方法
    • 自上而下的方法
  • 預測方法

第 3 章：執行摘要

第 4 章：簡介

  • 概述
  • 主要行業趨勢

第 5 章：全球產前與新生兒基因檢測市場

  • 市場概況
  • 市場業績
  • COVID-19 的影響
  • 市場預測

第 6 章：依產品類型分類的市場區隔

  • 耗材
    • 市場走向
    • 市場預測
  • 儀器
    • 市場走向
    • 市場預測

第 7 章：透過篩選進行市場區隔

  • 非侵入性產前檢測
    • 市場走向
    • 市場預測
  • 絨毛膜絨毛取樣
    • 市場走向
    • 市場預測
  • 羊膜穿刺術
    • 市場走向
    • 市場預測
  • 母體血清篩檢
    • 市場走向
    • 市場預測

第 8 章：疾病導致的市場區隔

  • 唐氏綜合症
    • 市場走向
    • 市場預測
  • 苯酮尿症
    • 市場走向
    • 市場預測
  • 囊腫纖維化
    • 市場走向
    • 市場預測
  • 鐮狀細胞性貧血
    • 市場走向
    • 市場預測

第 9 章：最終用戶的市場區隔

  • 醫院
    • 市場走向
    • 市場預測
  • 婦產科和專科診所
    • 市場走向
    • 市場預測
  • 診斷中心
    • 市場走向
    • 市場預測

第 10 章：按地區分類的市場細分

  • 北美洲
    • 美國
      • 市場走向
      • 市場預測
    • 加拿大
      • 市場走向
      • 市場預測
  • 亞太
    • 中國
      • 市場走向
      • 市場預測
    • 日本
      • 市場走向
      • 市場預測
    • 印度
      • 市場走向
      • 市場預測
    • 韓國
      • 市場走向
      • 市場預測
    • 澳洲
      • 市場走向
      • 市場預測
    • 印尼
      • 市場走向
      • 市場預測
    • 其他
      • 市場走向
      • 市場預測
  • 歐洲
    • 德國
      • 市場走向
      • 市場預測
    • 法國
      • 市場走向
      • 市場預測
    • 英國
      • 市場走向
      • 市場預測
    • 義大利
      • 市場走向
      • 市場預測
    • 西班牙
      • 市場走向
      • 市場預測
    • 俄羅斯
      • 市場走向
      • 市場預測
    • 其他
      • 市場走向
      • 市場預測
  • 拉丁美洲
    • 巴西
      • 市場走向
      • 市場預測
    • 墨西哥
      • 市場走向
      • 市場預測
    • 其他
      • 市場走向
      • 市場預測
  • 中東和非洲
    • 市場走向
    • 按國家/地區分類的市場細分
    • 市場預測

第 11 章：促進因素、限制與機會

  • 概述
  • 促進要素
  • 限制
  • 機會

第 12 章：價值鏈分析

第 13 章：波特五力分析

  • 概述
  • 買家的議價能力
  • 供應商的議價能力
  • 競爭程度
  • 新進入者的威脅
  • 替代品的威脅

第 14 章：價格分析

第15章：競爭格局

  • 市場結構
  • 關鍵參與者
  • 關鍵參與者簡介
    • Abbott Laboratories
    • BGI Group
    • Bio-Rad Laboratories Inc.
    • F. Hoffmann-La Roche AG
    • Illumina Inc.
    • Laboratory Corporation of America Holdings
    • Natera Inc.
    • PerkinElmer Inc.
    • Quest Diagnostics Incorporated
    • Ravgen Inc.
Product Code: SR112023A11196

Abstract

The global prenatal and newborn genetic testing market size reached US$ 5.3 Billion in 2022. Looking forward, IMARC Group expects the market to reach US$ 11.2 Billion by 2028, exhibiting a growth rate (CAGR) of 13.3% during 2022-2028. The growing demand for advanced diagnostic and screening devices, rising prevalence of congenital malformations and genetic abnormalities in newborn babies around the world, and thriving medical industry represent some of the key factors driving the market.

Prenatal and newborn genetic testing comprises blood tests, a specific type of ultrasound, and prenatal cell-free DNA screening that offers invaluable insights into the genetic makeup of unborn babies and newborns. It can identify certain birth defects, many of which are genetic disorders in unborn or newborn babies. It provides critical information to expectant parents, healthcare professionals, and researchers, enabling them to make informed decisions about the health and well-being of infants. It assists in improving patient outcomes and guiding medical interventions while enabling accurate identification of genetic variations and abnormalities during pregnancy and early infancy. It also aids in detecting various congenital conditions, such as Down syndrome, cystic fibrosis, sickle cell disease, and phenylketonuria. As it helps analyze various protein levels in the blood of parents to determine the risk for abnormal chromosome numbers in babies, the demand for prenatal and newborn genetic testing is rising across the globe.

Prenatal and Newborn Genetic Testing Market Trends:

At present, the rising demand for advanced diagnostic and screening devices among the masses across the globe represents one of the key factors supporting the growth of the market. In addition, there is an increase in the prevalence of congenital malformations and genetic abnormalities in newborn babies worldwide. This, along with the thriving medical industry, is propelling the growth of the market. Moreover, the growing demand for non-invasive prenatal screening methods due to their various benefits, such as high accuracy and precision, less pain, and fast diagnosis, as compared to conventional methods, is positively influencing the market. Besides this, the rising awareness among individuals about the benefits of prenatal and newborn genetic testing is offering lucrative growth opportunities to industry investors. Additionally, the escalating demand for prenatal and newborn genetic testing due to the increasing number of health-conscious individuals is contributing to the growth of the market. Apart from this, governing agencies of various countries are focusing on improving healthcare infrastructure to provide enhanced healthcare services to citizens. In line with this, key players are developing genetic eye tests to identify the risk of keratoconus and other corneal dystrophies in patients. Furthermore, the growing demand for cell-free DNA in maternal plasma tests to detect the risk of genetic disorders is offering a favorable market outlook.

Key Market Segmentation:

IMARC Group provides an analysis of the key trends in each segment of the global prenatal and newborn genetic testing market, along with forecasts at the global, regional, and country levels from 2023-2028. Our report has categorized the market based on product type, screening, disease, and end user.

Product Type Insights:

Consumables

Instruments

The report has provided a detailed breakup and analysis of the prenatal and newborn genetic testing market based on the product type. This includes consumables and instruments. According to the report, consumables represented the largest segment.

Screening Insights:

Non-invasive Prenatal Testing

Chorionic Villus Sampling

Amniocentesis

Maternal Serum Screening

A detailed breakup and analysis of the prenatal and newborn genetic testing market based on the screening has also been provided in the report. This includes non-invasive prenatal testing, chorionic villus sampling, amniocentesis, and maternal serum screening. According to the report, non-invasive prenatal testing accounted for the largest market share.

Disease Insights:

Downs Syndrome

Phenylketonuria

Cystic Fibrosis

Sickle Cell Anemia

A detailed breakup and analysis of the prenatal and newborn genetic testing market based on the disease has also been provided in the report. This includes downs syndrome, phenylketonuria, cystic fibrosis, and sickle cell anemia. According to the report, downs syndrome accounted for the largest market share.

End User Insights:

Hospital

Maternity and Specialty Clinics

Diagnostic Centers

A detailed breakup and analysis of the prenatal and newborn genetic testing market based on the end user has also been provided in the report. This includes hospital, maternity and specialty clinics, and diagnostic centers. According to the report, hospital accounted for the largest market share.

Regional Insights:

North America

United States

Canada

Asia Pacific

China

Japan

India

South Korea

Australia

Indonesia

Others

Europe

Germany

France

United Kingdom

Italy

Spain

Russia

Others

Latin America

Brazil

Mexico

Others

Middle East and Africa

The report has also provided a comprehensive analysis of all the major regional markets, which include North America (the United States and Canada); Asia Pacific (China, Japan, India, South Korea, Australia, Indonesia, and others); Europe (Germany, France, the United Kingdom, Italy, Spain, Russia, and others); Latin America (Brazil, Mexico, and others); and the Middle East and Africa. According to the report, North America was the largest market for prenatal and newborn genetic testing. Some of the factors driving the North America prenatal and newborn genetic testing market included the growing number of pregnant women undergoing genetic screening, rising awareness about various inborn genetic diseases, enhanced healthcare infrastructure, etc.

Competitive Landscape:

The report has also provided a comprehensive analysis of the competitive landscape in the global prenatal and newborn genetic testing market. Detailed profiles of all major companies have been provided. Some of the companies covered include Abbott Laboratories, BGI Group, Bio-Rad Laboratories Inc., F. Hoffmann-La Roche AG, Illumina Inc., Laboratory Corporation of America Holdings, Natera Inc., PerkinElmer Inc., Quest Diagnostics Incorporated, Ravgen Inc., etc. Kindly note that this only represents a partial list of companies, and the complete list has been provided in the report.

Key Questions Answered in This Report:

  • How has the global prenatal and newborn genetic testing market performed so far, and how will it perform in the coming years?
  • What are the drivers, restraints, and opportunities in the global prenatal and newborn genetic testing market?
  • What is the impact of each driver, restraint, and opportunity on the global prenatal and newborn genetic testing market?
  • What are the key regional markets?
  • Which countries represent the most attractive prenatal and newborn genetic testing market?
  • What is the breakup of the market based on the product type?
  • Which is the most attractive product type in the prenatal and newborn genetic testing market?
  • What is the breakup of the market based on the screening?
  • Which is the most attractive screening in the prenatal and newborn genetic testing market?
  • What is the breakup of the market based on the disease?
  • Which is the most attractive disease in the prenatal and newborn genetic testing market?
  • What is the breakup of the market based on the end user?
  • Which is the most attractive end user in the prenatal and newborn genetic testing market?
  • What is the competitive structure of the global prenatal and newborn genetic testing market?
  • Who are the key players/companies in the global prenatal and newborn genetic testing market?

Table of Contents

1 Preface

2 Scope and Methodology

  • 2.1 Objectives of the Study
  • 2.2 Stakeholders
  • 2.3 Data Sources
    • 2.3.1 Primary Sources
    • 2.3.2 Secondary Sources
  • 2.4 Market Estimation
    • 2.4.1 Bottom-Up Approach
    • 2.4.2 Top-Down Approach
  • 2.5 Forecasting Methodology

3 Executive Summary

4 Introduction

  • 4.1 Overview
  • 4.2 Key Industry Trends

5 Global Prenatal and Newborn Genetic Testing Market

  • 5.1 Market Overview
  • 5.2 Market Performance
  • 5.3 Impact of COVID-19
  • 5.4 Market Forecast

6 Market Breakup by Product Type

  • 6.1 Consumables
    • 6.1.1 Market Trends
    • 6.1.2 Market Forecast
  • 6.2 Instruments
    • 6.2.1 Market Trends
    • 6.2.2 Market Forecast

7 Market Breakup by Screening

  • 7.1 Non-invasive Prenatal Testing
    • 7.1.1 Market Trends
    • 7.1.2 Market Forecast
  • 7.2 Chorionic Villus Sampling
    • 7.2.1 Market Trends
    • 7.2.2 Market Forecast
  • 7.3 Amniocentesis
    • 7.3.1 Market Trends
    • 7.3.2 Market Forecast
  • 7.4 Maternal Serum Screening
    • 7.4.1 Market Trends
    • 7.4.2 Market Forecast

8 Market Breakup by Disease

  • 8.1 Downs Syndrome
    • 8.1.1 Market Trends
    • 8.1.2 Market Forecast
  • 8.2 Phenylketonuria
    • 8.2.1 Market Trends
    • 8.2.2 Market Forecast
  • 8.3 Cystic Fibrosis
    • 8.3.1 Market Trends
    • 8.3.2 Market Forecast
  • 8.4 Sickle Cell Anemia
    • 8.4.1 Market Trends
    • 8.4.2 Market Forecast

9 Market Breakup by End User

  • 9.1 Hospital
    • 9.1.1 Market Trends
    • 9.1.2 Market Forecast
  • 9.2 Maternity and Specialty Clinics
    • 9.2.1 Market Trends
    • 9.2.2 Market Forecast
  • 9.3 Diagnostic Centers
    • 9.3.1 Market Trends
    • 9.3.2 Market Forecast

10 Market Breakup by Region

  • 10.1 North America
    • 10.1.1 United States
      • 10.1.1.1 Market Trends
      • 10.1.1.2 Market Forecast
    • 10.1.2 Canada
      • 10.1.2.1 Market Trends
      • 10.1.2.2 Market Forecast
  • 10.2 Asia-Pacific
    • 10.2.1 China
      • 10.2.1.1 Market Trends
      • 10.2.1.2 Market Forecast
    • 10.2.2 Japan
      • 10.2.2.1 Market Trends
      • 10.2.2.2 Market Forecast
    • 10.2.3 India
      • 10.2.3.1 Market Trends
      • 10.2.3.2 Market Forecast
    • 10.2.4 South Korea
      • 10.2.4.1 Market Trends
      • 10.2.4.2 Market Forecast
    • 10.2.5 Australia
      • 10.2.5.1 Market Trends
      • 10.2.5.2 Market Forecast
    • 10.2.6 Indonesia
      • 10.2.6.1 Market Trends
      • 10.2.6.2 Market Forecast
    • 10.2.7 Others
      • 10.2.7.1 Market Trends
      • 10.2.7.2 Market Forecast
  • 10.3 Europe
    • 10.3.1 Germany
      • 10.3.1.1 Market Trends
      • 10.3.1.2 Market Forecast
    • 10.3.2 France
      • 10.3.2.1 Market Trends
      • 10.3.2.2 Market Forecast
    • 10.3.3 United Kingdom
      • 10.3.3.1 Market Trends
      • 10.3.3.2 Market Forecast
    • 10.3.4 Italy
      • 10.3.4.1 Market Trends
      • 10.3.4.2 Market Forecast
    • 10.3.5 Spain
      • 10.3.5.1 Market Trends
      • 10.3.5.2 Market Forecast
    • 10.3.6 Russia
      • 10.3.6.1 Market Trends
      • 10.3.6.2 Market Forecast
    • 10.3.7 Others
      • 10.3.7.1 Market Trends
      • 10.3.7.2 Market Forecast
  • 10.4 Latin America
    • 10.4.1 Brazil
      • 10.4.1.1 Market Trends
      • 10.4.1.2 Market Forecast
    • 10.4.2 Mexico
      • 10.4.2.1 Market Trends
      • 10.4.2.2 Market Forecast
    • 10.4.3 Others
      • 10.4.3.1 Market Trends
      • 10.4.3.2 Market Forecast
  • 10.5 Middle East and Africa
    • 10.5.1 Market Trends
    • 10.5.2 Market Breakup by Country
    • 10.5.3 Market Forecast

11 Drivers, Restraints, and Opportunities

  • 11.1 Overview
  • 11.2 Drivers
  • 11.3 Restraints
  • 11.4 Opportunities

12 Value Chain Analysis

13 Porters Five Forces Analysis

  • 13.1 Overview
  • 13.2 Bargaining Power of Buyers
  • 13.3 Bargaining Power of Suppliers
  • 13.4 Degree of Competition
  • 13.5 Threat of New Entrants
  • 13.6 Threat of Substitutes

14 Price Analysis

15 Competitive Landscape

  • 15.1 Market Structure
  • 15.2 Key Players
  • 15.3 Profiles of Key Players
    • 15.3.1 Abbott Laboratories
      • 15.3.1.1 Company Overview
      • 15.3.1.2 Product Portfolio
    • 15.3.2 BGI Group
      • 15.3.2.1 Company Overview
      • 15.3.2.2 Product Portfolio
    • 15.3.3 Bio-Rad Laboratories Inc.
      • 15.3.3.1 Company Overview
      • 15.3.3.2 Product Portfolio
    • 15.3.4 F. Hoffmann-La Roche AG
      • 15.3.4.1 Company Overview
      • 15.3.4.2 Product Portfolio
    • 15.3.5 Illumina Inc.
      • 15.3.5.1 Company Overview
      • 15.3.5.2 Product Portfolio
    • 15.3.6 Laboratory Corporation of America Holdings
      • 15.3.6.1 Company Overview
      • 15.3.6.2 Product Portfolio
    • 15.3.7 Natera Inc.
      • 15.3.7.1 Company Overview
      • 15.3.7.2 Product Portfolio
    • 15.3.8 PerkinElmer Inc.
      • 15.3.8.1 Company Overview
      • 15.3.8.2 Product Portfolio
    • 15.3.9 Quest Diagnostics Incorporated
      • 15.3.9.1 Company Overview
      • 15.3.9.2 Product Portfolio
    • 15.3.10 Ravgen Inc.
      • 15.3.10.1 Company Overview
      • 15.3.10.2 Product Portfolio

Kindly note that this only represents a partial list of companies, and the complete list has been provided in the report.

List of Figures

  • Figure 1: Global: Prenatal and Newborn Genetic Testing Market: Major Drivers and Challenges
  • Figure 2: Global: Prenatal and Newborn Genetic Testing Market: Sales Value (in Billion US$), 2017-2022
  • Figure 3: Global: Prenatal and Newborn Genetic Testing Market Forecast: Sales Value (in Billion US$), 2023-2028
  • Figure 4: Global: Prenatal and Newborn Genetic Testing Market: Breakup by Product Type (in %), 2022
  • Figure 5: Global: Prenatal and Newborn Genetic Testing Market: Breakup by Screening (in %), 2022
  • Figure 6: Global: Prenatal and Newborn Genetic Testing Market: Breakup by Disease (in %), 2022
  • Figure 7: Global: Prenatal and Newborn Genetic Testing Market: Breakup by End User (in %), 2022
  • Figure 8: Global: Prenatal and Newborn Genetic Testing Market: Breakup by Region (in %), 2022
  • Figure 9: Global: Prenatal and Newborn Genetic Testing (Consumables) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 10: Global: Prenatal and Newborn Genetic Testing (Consumables) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 11: Global: Prenatal and Newborn Genetic Testing (Instruments) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 12: Global: Prenatal and Newborn Genetic Testing (Instruments) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 13: Global: Prenatal and Newborn Genetic Testing (Non-invasive Prenatal Testing) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 14: Global: Prenatal and Newborn Genetic Testing (Non-invasive Prenatal Testing) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 15: Global: Prenatal and Newborn Genetic Testing (Chorionic Villus Sampling) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 16: Global: Prenatal and Newborn Genetic Testing (Chorionic Villus Sampling) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 17: Global: Prenatal and Newborn Genetic Testing (Amniocentesis) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 18: Global: Prenatal and Newborn Genetic Testing (Amniocentesis) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 19: Global: Prenatal and Newborn Genetic Testing (Maternal Serum Screening) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 20: Global: Prenatal and Newborn Genetic Testing (Maternal Serum Screening) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 21: Global: Prenatal and Newborn Genetic Testing (Downs Syndrome) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 22: Global: Prenatal and Newborn Genetic Testing (Downs Syndrome) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 23: Global: Prenatal and Newborn Genetic Testing (Phenylketonuria) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 24: Global: Prenatal and Newborn Genetic Testing (Phenylketonuria) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 25: Global: Prenatal and Newborn Genetic Testing (Cystic Fibrosis) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 26: Global: Prenatal and Newborn Genetic Testing (Cystic Fibrosis) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 27: Global: Prenatal and Newborn Genetic Testing (Sickle Cell Anemia) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 28: Global: Prenatal and Newborn Genetic Testing (Sickle Cell Anemia) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 29: Global: Prenatal and Newborn Genetic Testing (Hospital) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 30: Global: Prenatal and Newborn Genetic Testing (Hospital) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 31: Global: Prenatal and Newborn Genetic Testing (Maternity and Specialty Clinics) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 32: Global: Prenatal and Newborn Genetic Testing (Maternity and Specialty Clinics) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 33: Global: Prenatal and Newborn Genetic Testing (Diagnostic Centers) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 34: Global: Prenatal and Newborn Genetic Testing (Diagnostic Centers) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 35: North America: Prenatal and Newborn Genetic Testing Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 36: North America: Prenatal and Newborn Genetic Testing Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 37: United States: Prenatal and Newborn Genetic Testing Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 38: United States: Prenatal and Newborn Genetic Testing Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 39: Canada: Prenatal and Newborn Genetic Testing Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 40: Canada: Prenatal and Newborn Genetic Testing Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 41: Asia-Pacific: Prenatal and Newborn Genetic Testing Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 42: Asia-Pacific: Prenatal and Newborn Genetic Testing Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 43: China: Prenatal and Newborn Genetic Testing Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 44: China: Prenatal and Newborn Genetic Testing Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 45: Japan: Prenatal and Newborn Genetic Testing Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 46: Japan: Prenatal and Newborn Genetic Testing Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 47: India: Prenatal and Newborn Genetic Testing Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 48: India: Prenatal and Newborn Genetic Testing Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 49: South Korea: Prenatal and Newborn Genetic Testing Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 50: South Korea: Prenatal and Newborn Genetic Testing Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 51: Australia: Prenatal and Newborn Genetic Testing Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 52: Australia: Prenatal and Newborn Genetic Testing Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 53: Indonesia: Prenatal and Newborn Genetic Testing Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 54: Indonesia: Prenatal and Newborn Genetic Testing Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 55: Others: Prenatal and Newborn Genetic Testing Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 56: Others: Prenatal and Newborn Genetic Testing Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 57: Europe: Prenatal and Newborn Genetic Testing Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 58: Europe: Prenatal and Newborn Genetic Testing Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 59: Germany: Prenatal and Newborn Genetic Testing Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 60: Germany: Prenatal and Newborn Genetic Testing Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 61: France: Prenatal and Newborn Genetic Testing Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 62: France: Prenatal and Newborn Genetic Testing Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 63: United Kingdom: Prenatal and Newborn Genetic Testing Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 64: United Kingdom: Prenatal and Newborn Genetic Testing Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 65: Italy: Prenatal and Newborn Genetic Testing Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 66: Italy: Prenatal and Newborn Genetic Testing Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 67: Spain: Prenatal and Newborn Genetic Testing Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 68: Spain: Prenatal and Newborn Genetic Testing Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 69: Russia: Prenatal and Newborn Genetic Testing Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 70: Russia: Prenatal and Newborn Genetic Testing Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 71: Others: Prenatal and Newborn Genetic Testing Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 72: Others: Prenatal and Newborn Genetic Testing Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 73: Latin America: Prenatal and Newborn Genetic Testing Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 74: Latin America: Prenatal and Newborn Genetic Testing Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 75: Brazil: Prenatal and Newborn Genetic Testing Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 76: Brazil: Prenatal and Newborn Genetic Testing Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 77: Mexico: Prenatal and Newborn Genetic Testing Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 78: Mexico: Prenatal and Newborn Genetic Testing Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 79: Others: Prenatal and Newborn Genetic Testing Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 80: Others: Prenatal and Newborn Genetic Testing Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 81: Middle East and Africa: Prenatal and Newborn Genetic Testing Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 82: Middle East and Africa: Prenatal and Newborn Genetic Testing Market: Breakup by Country (in %), 2022
  • Figure 83: Middle East and Africa: Prenatal and Newborn Genetic Testing Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 84: Global: Prenatal and Newborn Genetic Testing Industry: Drivers, Restraints, and Opportunities
  • Figure 85: Global: Prenatal and Newborn Genetic Testing Industry: Value Chain Analysis
  • Figure 86: Global: Prenatal and Newborn Genetic Testing Industry: Porter's Five Forces Analysis

List of Tables

  • Table 1: Global: Prenatal and Newborn Genetic Testing Market: Key Industry Highlights, 2022 and 2028
  • Table 2: Global: Prenatal and Newborn Genetic Testing Market Forecast: Breakup by Product Type (in Million US$), 2023-2028
  • Table 3: Global: Prenatal and Newborn Genetic Testing Market Forecast: Breakup by Screening (in Million US$), 2023-2028
  • Table 4: Global: Prenatal and Newborn Genetic Testing Market Forecast: Breakup by Disease (in Million US$), 2023-2028
  • Table 5: Global: Prenatal and Newborn Genetic Testing Market Forecast: Breakup by End User (in Million US$), 2023-2028
  • Table 6: Global: Prenatal and Newborn Genetic Testing Market Forecast: Breakup by Region (in Million US$), 2023-2028
  • Table 7: Global: Prenatal and Newborn Genetic Testing Market: Competitive Structure
  • Table 8: Global: Prenatal and Newborn Genetic Testing Market: Key Players